- Gounder Gives Lowdown on Ebola, Peptides, and Colorectal Screenings
- ASCO: Pfizer one-ups J&J with Talzenna combo's broad castration-sensitive prostate cancer win
- ASCO: With bispecifics on its heels, Incyte positions Monjuvi combo for first-line DLBCL
- 6 dental technology updates in May
- From clinician to leader: Building confidence, capability and leadership in dentistry
- Operationalizing AI at scale: A practical framework for enterprise-scale success
- 3 key stats on the orthodontist workforce
- Meet the COOs of 10 specialty DSOs
- Data, cross-training, and pipeline development: How health systems are rethinking OR staffing
- How top health systems are redefining the digital patient experience
- ‘The most significant change in 20 years’: Cancer centers prepare for daraxonrasib demand
- A Smooth Handoff From Decision to Dollars: Connecting the Last Mile in Healthcare Payments
- Budget-Strapped Montana Will Stress-Test Trump’s Medicaid Work Rules
- How CEOs actually use hospital rankings — and when they don’t
- What OU Health’s founding CEO learned building a new health system
- Arkansas hospital CEO to step down after 11 years for new role
- The behavioral health workforce pipeline: Where it stands and where it’s headed
- 6 major investments in youth behavioral health
- Coalition for Health AI unveils governance playbook for systems
- 66 health systems ranked by long-term debt
- UnitedHealthcare drops some prior auth requirements for cardiology, orthopedic services
- 8 No Surprises Act shake-ups physicians need to know
- The ASC independence playbook: 3 leaders’ thoughts
- Dr. Rahimah Maina opens new dental practice
- GWU offloaded its $450M physician group problem — why the industry watching
- The gastroenterologist pay gap
- Texas surgery center to double in size, add 2 ORs
- What dental leaders told us in May
- Climate Change: Statement on Proposed Rescission of Climate-Related Disclosure Rules
- Kenyan Court Blocks Trump's Plan To Quarantine Ebola Patients
- What’s going on at the FTC? 3 notes for ASC leaders
- 8 DSOs making headlines
- The physician noncompete battle in 5 key figures
- The physician red flags that can predict a bad ASC partner
- Patient death draws renewed CMS scrutiny at HCA’s Mission Hospital
- Nearly 70% of US counties lack a GI: 13 concerning workforce stats
- Statement of Commissioner Mark T. Uyeda on the Rescission of Climate-Related Disclosure Rules
- A new behavioral health profession is born
- Keynote Remarks at the 2026 Reagan National Economic Forum
- Statement on Proposing Release for Rescission of Climate-Related Disclosure Rules
- Dentists’ pay climbed the most in these 10 states
- Mental Health Disorders Now No. 1 Cause of Disability Worldwide
- Massachusetts AG sues UnitedHealthcare over alleged Medicaid fraud
- UnitedHealthcare to nix nearly two thirds of pediatric prior auths
- Industry Voices—Patients are building a new healthcare system. The industry is finally catching up
- Weekly Rundown—Moffitt Cancer Center expands Reimagine Care's virtual oncology model; Tanner Health deploys AI workforce solution
- Study: LA Canine Outbreak Caused By Low Vaccination Rates, Crowded Boarding
- Ocrelizumab Effective In Slowing Progressive MS, Trial Shows
- Long COVID Might Be Twice As Common As Previously Thought
- In Vaccine-Skeptical California County, A Potential Playbook To Contain Measles
- Heavy Drinking Harms College Students' Brain Power, Study Finds
- A Trump Stronghold Grapples With Health Risks of ICE Detention Sites
- After Her Bout of Amnesia, a $59,000 Billing Dispute Wouldn’t Go Away
- Pharma urged to modernize patient support as young adult cancer rates rise
- Philips adds a spoonful of Disney sugar to ease kids’ MRI anxieties
- MannKind seeks long-awaited sales boost with inhaled insulin approval for kids
- Aetna to launch ‘on demand’ virtual mental health services in 2027
- U of Connecticut dental school reappoints dean for 2nd term
- Michigan dentist charged with Medicaid fraud
- Brand-name drug prices climb after launch in US, fall abroad amid MFN push: report
- ASCO: After Takeda’s defeat, Dizal picks up baton to take on J&J in EGFR lung cancer subtype
- Acadia in the headlines: 6 things to know
- 26 behavioral health executive moves to know
- AstraZeneca gains 2nd bladder cancer nod in key expansion for Imfinzi
- Advocate Health grows Q1 revenue by 10.8% amid higher volumes, greater efficiency
- Behavioral health hospital operator to pay $32M in Medicare fraud settlement
- Bangladesh Measles Surge Kills 500+ Children; Vaccine Delays Blamed
- Care navigation startup Garner Health banks $100M series E at $2.74B valuation
- HCA bolsters workforce pipeline with healthcare professional college acquisition
- Plant-Based Diet May Cut Obesity Risk For Women In Menopause
- Pharma leaders meet with PM Takaichi in push for Japan to retain R&D edge
- Penn Medicine, K Health partner to deploy AI clinical agents
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CMS finalizes changes to No Surprises Act dispute resolution process
- Smartwatch App Accurately Detects Major Epileptic Seizures
- Racial Gap Exists For Asthma Inhaler Use
- New Colon Cancer Screening Guidelines Add Blood And At-Home Tests
- Fierce Pharma Asia—More China biotech hawkishness; Pfizer’s $10B Innovent deal; Astellas’ roadmap
- CVS expands partnership with Salesforce for greater call center personalization
- Nurse Convicted In Patient's Death Turns Fatal Drug Error Into Cautionary Tale
- Wearable Ultrasound Patch Monitors High-Risk Pregnancies In Real Time
- In a Vaccine-Skeptical California County, a Potential Playbook To Contain Measles
- Listen to the Latest ‘KFF Health News Minute’
- Teladoc Health inks partnership with Walmart to expand virtual care services
- PharmaEssentia taps Incyte alum Eric Vogel as it eyes Besremi expansion
- Kaléo speaks up on allergy awareness to amplify patient stories
- Privacy and PetShops: Remarks at the Regulatory PETshop Series: Cryptographic Technologies and Financial Services Regulation
- NYC Health + Hospitals adds 2nd behavioral health housing site
- Mindfulness isn’t a perk anymore — it’s a workforce strategy
- With Elahere building steam, AbbVie nets FDA nod for another ImmunoGen cancer asset
- Hospitals again ask FTC, DOJ for exemption from expanded premerger notification filings
- Coalition for Health AI unveils governance playbooks for responsible AI adoption
- Amazon taps Roy Schoenberg to lead healthcare business as Neil Lindsay plans to step down
- Viridian, awaiting FDA decision, taps WuXi Bio in eye drug supply deal
- U.S. To Keep Ebola-Exposed Citizens In Kenya Under New Policy
- CAT on a Hot Tin Roof
- GLP-1 Meds May Help Slow the Spread of Certain Obesity-Related Cancers
- GoodRx launches subscription program for low-cost generic medications, telehealth services
- George Washington University locks deal to hand off debt-ridden physician practice to UHS
- Humana invests $83M in new Florida pharmacy distribution center
- As J&J separates from its orthopedics business, it's laying off 56 employees in New Jersey
- ASCO preview: With expectations jacked up, Akeso's ivonescimab to face scrutiny in high-stakes plenary
- An insider’s look at LillyDirect
- GLP-1 manufacturer CordenPharma strikes deal for peptide CDMO, lining up new production sites in US and China
- Weight-Loss Program Helps Women Battling Breast Cancer
- Younger U.S. Women of Color Face Rising Breast Cancer Deaths
- High Fitness Doesn’t Raise A-fib Risk In Young Men, Study Finds
- Cheaper, Alternative Health Plans Are Having A Moment, But Critics Urge Caution
- Ultrafine Wildfire Smoke Particles May Pose Serious Health Risks
- Montana Hurries To Adopt Trump’s Medicaid Work Rules Amid Budget Woes
- Readers Address Drugged Driving, Suicide Prevention, Worker Shortages
- Nurse Convicted in Patient’s Death Turns Fatal Drug Error Into a Cautionary Tale
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Biogen investigated by Italian regulator over multiple sclerosis ‘market abuse’ claims
- FDA delays ruling on AstraZeneca’s breast cancer drug after negative adcomm vote
- Eli Lilly wins argument over Noom’s GLP-1 dosing claims
- Remarks at the Stanford Rock Center for Corporate Governance
- Smart ring maker Oura files confidentially for IPO as consumer demand propels revenue growth
- Outlook moves toward potential US nod for thrice-snubbed eye drug with FDA appeal win
- JD Power: Cost pressures worsen member experience with commercial plans
- Trump Admin Bars Key U.S. Researchers From Global Virus Response Talk
- Listen to the Latest ‘KFF Health News Minute’
- As calls for COINS Act expansion grow, will new rules sweep up China biotech licensing?
- Everyone Has A Family Doc, But Can You Get An Appointment?
- Many U.S. College Students With Psychosis Are Not Receiving Treatment
- Antibiotics Won't Help Ease Asthma-Linked Wheezing in Kids
- Yoga Eases Insomnia And Anxiety In Cancer Survivors, Study Finds
- Dust Yields Clues to Viral Outbreaks, Study Finds
- 3 Medical Routines That Older People May Not Need
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Video Game Can Detect Depression In Minutes, Study Says
- Quitting Smoking Might Lower Your Dementia Risk
- Severe Asthma Often Comes With Other Serious Health Problems
- Efforts To Understand The Nation's Drugged Driving Problem Stall Under Trump
- RFK Jr. Fires Two Leaders Of Major U.S. Health Task Force
- Common Food Preservatives Linked to Major Heart Problems
- Migraine With Aura Linked To Middle-Age Stroke Risk
- Nicotine Vapes Triple Smokers' Odds Of Quitting Tobacco
- Fatty Liver Disease Increases Heart Attack Risk, Study Says
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Statement on Novel Exchange-Traded Funds (ETFs)
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
Interlochen Public Radio interviewed personnel from the Michigan State Police (MSP) Forensic Science Division (FSD) and Harm Reduction Michigan about the changing nature of illegal drugs being confiscated in Michigan:
https://www.michigan.gov/msp/divisions/forensic-science
Purer meth, less pure opioids, more cocaine hit Michigan, testing reveals
By Maxwell Howard of Interlochen Public Radio | February 14, 2026Mexican drug cartels are shipping purer forms of meth into rural Michigan, replacing the drugs that were once made in home labs and full of impurities, police and lab testing data shows.
Meanwhile, opioids have been cut with more impurities that can render overdose treatment ineffective and cocaine use is on the rise, the data shows.
The lab results show rural parts of the state are rife with methamphetamine, cities have more cocaine, and opioids are everywhere in lesser amounts.
While Michigan’s drug overdose deaths have fallen from a high of 3,000 in 2021 to just more than 1,900 in 2024, the most recent state data shows, drug use remains high. Some 269,000 Michiganders 12 and older reported using illicit drugs other than marijuana in 2023 and 2024, the most recent federal data shows.
Local production of meth has grinded to a halt within the last five years, said Elaine Dougherty, lab manager at the Michigan State Police Bridgeport crime lab.
“Now, we get the crystal meth from the drug cartels,” said Doughterty. “It's not made from Sudafed anymore. It's not made in pop bottles anymore. It's literally made in factories in Mexico.”
In Grayling, about 60% of the drugs tested at that crime lab are meth, while Marquette comes in over 80%. Opioids and cocaine each make up roughly 10% to 15% in those labs.
While cocaine is a smaller percentage of the drugs tested across the state, Dougherty said the drug is more popular than it’s been in years, driven in part by increased production in South and Central America.
The number of tests run for cocaine at State Police crime labs statewide has almost doubled within the last three years — from 15% to 28%. That follows global trends showing the number of global cocaine users has grown to 25 million people in 2023, up from 17 million a decade earlier, according to the United Nation’s 2025 World Health Report.
That report says an estimated 3,708 tons of cocaine were manufactured in 2023, increasing by almost 1,000 tons from the year before. The increased supply has increased access and purity of the drug for users.
Opioids, Dougherty said, are the most heavily adulterated drugs on Michigan’s market, with around 20% of synthetic fentanyl samples containing xylazine, a sedative often paired with opioids for its similar effects.
Xylazine does not act on the same opioid receptors pathway, so opioid overdose reversal medication such as Naloxone does not work.
“We were rarely seeing large amounts of xylazine in a sample,” said Doughtery. “I know on the East Coast, they were seeing samples with five times as much xylazine as fentanyl.”
Xylazine levels peaked in Michigan in early 2025, according to MSP lab data, being found in 34% of fentanyl samples. That gradually declined at the end of the year.
Another non-opioid veterinary sedative, medetomidine, has increased from being non-existent in the last year to being found in over 12% of fentanyl samples. That drug behaves much in the same way as xylazine, but is 100 times more potent.
In 2024, three overdoses in Michigan were linked to medetomidine, leading state health officials to raise the alarm.
Damage by xylazine can result in deep skin wounds by restricting blood flow and damaging tissue.
Staff at Traverse City’s Harm Reduction MI office report treating xylazine wounds occasionally — usually with groups and in small timeframes.
“If fentanyl with xylazine makes it to Traverse City, it's likely several people are ingesting it. Especially if you always get your drugs from the same source,” said Dougherty.
One reason for that risk, she said, is that local dealers often don’t know what’s in the drugs.
“The dealers don't know when their stuff has xylazine in it,” said Dougherty. “In an odd way, (dealers) take pride in what they sell. So if they are saying they're selling cocaine, they want those customers to come back. So they want it to be cocaine that they're selling.”
Harm Reduction also tests drugs across the state, but at a different entry point than the State Police. While the state labs test drugs after they are confiscated, Harm Reduction MI tests drugs while they are on the street.
Director Pamela Lynch said most people usually find the nonprofit through word of mouth and come to test their drugs after a bad reaction. Harm Reduction’s testing data often includes more minute data than the state lab, which reports drug mixtures and cocktails.
Lynch’s lab data also reports different cocktails, but also reveals smaller adulterants — substances which appear in drugs incidentally or for little known purposes.
Around two months back, Lynch said, a woman brought in a substance to be tested after her boyfriend had an especially bad reaction and had trouble communicating. The sample later came back with results of PVC plastic.
“A lot of times, people know there's a lot of stuff in there that doesn't belong in there,” said Lynch.
Common adulterants include caffeine, acetaminophen, lidocaine, antidepressants and sugars. Sometimes, the substances are unexpected.
“We even had a sample recently with flower dye,” said Lynch. “The flower dye actually ends up making little spots on their skin.”
Whether knowing what’s in illegal drugs changes behavior — for dealers or people in active addiction — is unclear. But for Lynch, the purpose of her lab is to keep people as healthy as they can until a person is ready for recovery.
“They may think that they have a safe supply. They may trust their dealer,” said Lynch. “They all know they're buying fentanyl. They don't know that they're buying xylazine until they test it.”
This reporting is made possible by the Northern Michigan Journalism Collaborative, led by Bridge Michigan and Interlochen Public Radio, and funded by Press Forward Northern Michigan.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















